These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12593166)

  • 1. [Prospects in the search for new biological agents to prevent tuberculosis].
    Kolomiets VM; Evglevskiĭ AA; Kovalenko AM; Timkova EA
    Probl Tuberk; 2002; (10):31-3. PubMed ID: 12593166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG protects toddlers during a tuberculosis outbreak.
    Gaensbauer JT; Vandaleur M; O'Neil M; Altaf A; Ní Chróinín M
    Arch Dis Child; 2009 May; 94(5):392-3. PubMed ID: 19190006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
    Murphy D; Corner LA; Gormley E
    Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse and guinea pig models for testing new tuberculosis vaccines.
    Orme IM
    Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective value of BCG vaccine.
    Udani PM
    Indian Pediatr; 1982 Sep; 19(9):739-52. PubMed ID: 6984429
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations.
    Basaraba RJ; Izzo AA; Brandt L; Orme IM
    Vaccine; 2006 Jan; 24(3):280-6. PubMed ID: 16153758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The search for ways to improve the efficacy of tuberculosis revaccination in children with immunological deficiency].
    Chernushenko EF; Kadan LP; Kruglova IF; Podgainaia EA
    Probl Tuberk; 1996; (1):29-32. PubMed ID: 8907482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil.
    Antas PR; Castello-Branco LR
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):628-30. PubMed ID: 18440575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222.
    Bachvarova M; Stefanova T; Nikolaeva S; Chouchkova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):1010-5. PubMed ID: 19393344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
    Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
    Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic methods of postvaccinal complications after administration of BCG vaccine].
    Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziołkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
    Przegl Epidemiol; 2004; 58 Suppl 1():123-8. PubMed ID: 15807170
    [No Abstract]   [Full Text] [Related]  

  • 17. Current progress in tuberculosis vaccine development.
    Orme IM
    Vaccine; 2005 Mar; 23(17-18):2105-8. PubMed ID: 15755579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tubercle bacilli and the infection theory].
    Yamamoto K
    Kekkaku; 1980 Oct; 55(10):457-61. PubMed ID: 6785509
    [No Abstract]   [Full Text] [Related]  

  • 19. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.
    Guex-Crosier Y; Chamot L; Zografos L
    Klin Monbl Augenheilkd; 2003 Mar; 220(3):193-5. PubMed ID: 12664378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.